Consultant Cardiologist | Heart Center 🇩🇪 @UniklinikBonn | Clinician Scientist | Project Leader @trr259 | Editorial Board Member @BMC_series
University Hospital Bonn
Joined March 2020
- Tweets472
- Following1.2K
- Followers1.5K
- Likes2.2K
Baravan Al-Kassou | MD retweeted
先日のパリ学会中でのインタビュー
JACC cardio. Intervention に掲載された論文の事なんですが、
実は学会で場所が無く、静かな場所を求めて、急遽知人のホテルに転がり込ませてもらって収録した一本
What are the outcomes of #T_TEER in patients with #primary_TR? Check out this interview with @AtsushiSssugi discussing their #JACCINT manuscript
jacc.org/doi/10.1016/j.jcin.…
#CardioX #ACCFIT
Baravan Al-Kassou | MD retweeted
Severe multiple valvular heart disease increases mortality after #TAVR, with tricuspid regurgitation posing the highest risk.
Read how staged transcatheter edge‐to‐edge repair improves outcomes. #AHAJournals @bara_doc @UniklinikBonn ahajrnls.org/44ohgX1
Baravan Al-Kassou | MD retweeted
🎙️NEW #CRT2025 Interview 💫@bara_doc discusses insights from the GUARD study on the progression and outcomes of mild to moderate #aortic #stenosis.
📽️Watch here👉 ow.ly/qKqK50VfTz9
#CardioEd #CardioTwitter
Baravan Al-Kassou | MD retweeted
In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse cardiovascular events over a median follow-up period of 3 years. Full trial results and Research Summary: nej.md/4i2U6dV
ALT Colchicine in Acute Myocardial Infarction A Research Summary based on Jolly SS et al. | 10.1056/NEJMoa2405922 | Published on November 17, 2024 Visual representations of the patients in the trial and the treatments they were assigned. Read the full Research Summary at NEJM.org.
Baravan Al-Kassou | MD retweeted
Ihr forscht zum Thema interventionelle Kardiologie? ⬇️EURE CHANCE ⬇️
Noch bis morgen Euer Projekt für den Andreas-Grüntzig-Forschungspreis einreichen ✊
Alle Infos:
herzmedizin.de/fuer-aerzte-u…
@AGIKinterv @YoungDgk @DGK_org @Kardiophil @TSchneiderMD @KardiologieHH @bara_doc
Baravan Al-Kassou | MD retweeted
SGLT2i can reduce the incidence of new-onset diabetes among individuals with cardiovascular or kidney disease. Read more in #EHJ 👉 bit.ly/4eMWqTe
@RoccoMontone @ehj_ed #diabetes
Baravan Al-Kassou | MD retweeted
A tale of measured and predicted prosthesis-patient-mismatch #PPM after #TAVR - an analysis of the #IMPPACT TAVI registry by @HenningGuthoff just published in @JACCJournals #JACCInt, accompanied by an editorial of the godfather of PPM @PPibarot
bit.ly/3V93T8p
🧵(1/8)
Baravan Al-Kassou | MD retweeted
Presented at #AHA24:
Among patients with ventricular tachycardia and ischemic cardiomyopathy, catheter ablation as an initial therapy led to a lower risk of adverse outcomes than antiarrhythmic drug therapy. Read the full VANISH2 trial results: nej.md/3Z5ECOD
ALT Kaplan–Meier analysis of the primary end point.
Baravan Al-Kassou | MD retweeted
BREAKING NEWS
The 2024 #NobelPrize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.
Baravan Al-Kassou | MD retweeted
Hospitation im Hybrid-Op bei einer #TAVI? 🤩🫀
Von Zugangsweg über Prothesenpräparation bis hin zum Verschlusssystem 👀
Alles eine Frage des #Teamwork 🤝
Hier gibt es das ganze Video: youtu.be/Vtb9CuOY1CA?si=Cz_V…
@AtsushiSssugi @bara_doc @MAlZaidi_ @AndreasZietzer @HubrichtD
Baravan Al-Kassou | MD retweeted
Among various #myocarditis diagnostic criteria, ESC criteria for clinically suspected myocarditis and updated Lake Louise criteria had the highest prognostic value. bit.ly/4eKsVSl
#JACC @chrisgraeni
Baravan Al-Kassou | MD retweeted
Der zweite Showtag @DGK_org kann beginnen! Auf dem Programm stehen 1️⃣6️⃣ spannende @AGIKinterv Sessions:
🔥 4️⃣ Workshops 📍Saal C
🔥 2️⃣ Sessions speziell für Assistenzpersonal 📍Saal X1
🔥 3️⃣ AGIK Cinema-Sessions📍Saal X3
🔥 7️⃣ interessante Sessions 📍Saal G1 und Saal 3
Baravan Al-Kassou | MD retweeted
#EssenFeelsTheBeat @SMathewi über #Cannabis und #Afib
🔹Cannabiskonsum steigt in Europa
🔹Akut: Verdopplung der Herzfrequenz für bis zu 3h
🔹 Chronisch: AV-Blockierung möglich
🔹insgesamt erhöhte Inzidenz von atrialen Tachykardien
@EssenBeat @TRassafMD @SMathewi @UniklinikEssen
Baravan Al-Kassou | MD retweeted
In the NOTION-3 trial of percutaneous coronary intervention or conservative treatment in patients undergoing TAVI, PCI was associated with a lower risk of a composite of death, MI, or urgent revascularization at a median of 2 years. Full results: nej.md/3AH5WJo #ESCardio
ALT Panel A: A Kaplan–Meier plot and estimate for the primary end point, defined as a composite of death from any cause, myocardial infarction, or urgent revascularization. Panels B–D: Secondary end-point data for the individual components of the primary end point, death from any cause, myocardial infarction, and urgent revascularization.
Baravan Al-Kassou | MD retweeted
2024 #ESCGuidelines for the management of chronic coronary syndromes: Developed by the task force for the management of chronic coronary syndromes of ESC @escardio and endorsed by @EACTS. #EHJ
academic.oup.com/eurheartj/a…
#ESCCongress @escardio @ESC_Journals #CCS #guidelines
Baravan Al-Kassou | MD retweeted
Interesse an der interventionellen Kardiologie? 🫀〰️
@bara_doc @realdocdan @HubrichtD @LuisEichelmann @HenrikeHillmann
Alles, was Ihr für den Einstieg braucht ⬇️⬇️⬇️⬇️⬇️
Die ersten Jahre einer kardiologischen Karriere können herausfordernd sein. Zum Glück gibt es Unterstützung. 🙂 Am 12. & 13.09. in Hannover: "Young DGK Interaktiv - Spotlight Interventionelle Kardiologie". Jetzt anmelden!
👉 akademie.dgk.org/veranstaltu… #DGK #DGKAkademie #YoungDGK
Baravan Al-Kassou | MD retweeted
Case reports @EHJCREiC - great opportunity for new collaborations
@Hannah_Billig_ @gkorosoglou #FlorianAndre #NorbertFrey
@Phiso_de @chris_sohns @dirkwestermann @thiele_holger @Herzmedizin_de @doc_cardio @YoungDgk @bara_doc @AGIKinterv
doi.org/10.1093/ehjcr/ytae30…
Baravan Al-Kassou | MD retweeted
Great Debate: Should SGLT2 inhibitors be first-line treatment in heart failure with reduced ejection fraction? #EHJ
academic.oup.com/eurheartj/a…
#SGLT2i #HFrEF @escardio @ESC_Journals
Baravan Al-Kassou | MD retweeted
EHJ issue 45 - 18 is online:
Dive into ischaemic heart disease, exploring the safety of colchicine, the brain-heart axis, and promising new targets for ischemia-reperfusion injury.
academic.oup.com/eurheartj/i…
@escardio @ESC_Journals #EHJ #cardiotwitter
